Neurotech startup NeuroHealth has secured a record-breaking $700 million funding round, with Series C investment from Lightspeed Venture Partners and co-led by O.G. Venture Partners. The new funding will enable the company to further expand its AI-powered body scans in the United States.
Neko Health's flagship service combines medical imaging, blood tests, proprietary sensors, and clinician review to provide a comprehensive preventive screening experience. This technology allows for accurate diagnoses of various health conditions at an early stage, enabling personalized treatment plans tailored to individual needs.
The funding will be used to establish Neko Health's clinic in New York, where patients can undergo AI-powered body scans and receive immediate analysis from expert clinicians. The company aims to make its services accessible to a broader audience, including underserved communities that may not have access to regular medical check-ups or advanced diagnostic tools.